共 50 条
- [1] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Paz-Ares, L. G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainDe Marinis, F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainDediu, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainThomas, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainPujol, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainBidoli, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainMolinier, O.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainSahoo, T. P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainLaack, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainReck, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainCorral, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainMelemed, S. A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainJohn, W. J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainChouaki, N.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainZimmerman, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainGrul, C. M. Visseren论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, SpainGridelli, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain
- [2] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)Paz-Ares, L. G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainDe Marinis, F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainDediu, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainThomas, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainPujol, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainBidoli, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainMolinier, O.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainSahoo, T. P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainLaack, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainReck, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainCorral, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainMelem, S. A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainGrul, C. M. Visseren论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, SpainGridelli, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, Spain
- [3] UPDATED SAFETY AND QUALITY OF LIFE (QOL) RESULTS OF PARAMOUNT STUDY: MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VS PLACEBO (PBO) PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEM PLUS CISPLATIN (CP) FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)[J]. ANNALS OF ONCOLOGY, 2012, 23 : 418 - 419Pujol, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, France Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FrancePaz-Ares, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceDediu, M.论文数: 0 引用数: 0 h-index: 0机构: Fundeni Clin Hosp Alexandru Treistoreanu, Inst Oncol Bucharest, Bucharest, Romania Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceThomas, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg, Thoraxklin Heidelberg, Dept Thorac Oncol, D-6900 Heidelberg, Germany Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceBidoli, P.论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped S Gerardo UO Oncol Med, Monza, Italy Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceCorral, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceChouaki, N.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Dept Med, Paris, France Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceVisseren-Grul, C. M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Oncol Europe, Ra Houten, Netherlands Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceZimmermann, A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, FranceGridelli, C.论文数: 0 引用数: 0 h-index: 0机构: UO Oncol Med SG Moscati Hosp, Avellino, Italy Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, France
- [4] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)[J]. ONKOLOGIE, 2012, 35 : 36 - 37Laack, E.论文数: 0 引用数: 0 h-index: 0机构: Ambulantes Krebszentrum, Hamburg, Germany Ambulantes Krebszentrum, Hamburg, GermanyReck, M.论文数: 0 引用数: 0 h-index: 0机构: Krankenhaus Grosshansdorf, Grosshansdorf, Germany Ambulantes Krebszentrum, Hamburg, GermanySchumann, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm Klinikum, Sekt Pneumol, Ulm, Germany Ambulantes Krebszentrum, Hamburg, GermanyEschbach, C.论文数: 0 引用数: 0 h-index: 0机构: Asklepios Klin Hamburg, Hamburg, Germany Ambulantes Krebszentrum, Hamburg, GermanyKimmich, M.论文数: 0 引用数: 0 h-index: 0机构: Klin Schillerhohe, Gerlingen, Germany Ambulantes Krebszentrum, Hamburg, GermanyBrandts, C.论文数: 0 引用数: 0 h-index: 0机构: Uniklin, Frankfurt, Germany Ambulantes Krebszentrum, Hamburg, GermanyPaz-Ares, L. G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Ambulantes Krebszentrum, Hamburg, GermanyDe Marinis, F.论文数: 0 引用数: 0 h-index: 0机构: San Camillo Forlanini Hosp, Rome, Italy Ambulantes Krebszentrum, Hamburg, GermanyDediu, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Oncol Bucharest, Bucharest, Romania Ambulantes Krebszentrum, Hamburg, GermanyPujol, J.-L.论文数: 0 引用数: 0 h-index: 0机构: Montpellier Univ Hosp, Montpellier, France Ambulantes Krebszentrum, Hamburg, GermanyBidoli, P.论文数: 0 引用数: 0 h-index: 0机构: Az Osped S Gerardo, Monza, Italy Ambulantes Krebszentrum, Hamburg, GermanyMolinier, O.论文数: 0 引用数: 0 h-index: 0机构: Les Mans Reg Hosp, Le Mans, France Ambulantes Krebszentrum, Hamburg, GermanySahoo, T. P.论文数: 0 引用数: 0 h-index: 0机构: Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, India Ambulantes Krebszentrum, Hamburg, GermanyCorral, J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Ambulantes Krebszentrum, Hamburg, GermanyMelemed, S. A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Ambulantes Krebszentrum, Hamburg, GermanyJohn, W. J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Ambulantes Krebszentrum, Hamburg, GermanyChouaki, N.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Suresnes, France Ambulantes Krebszentrum, Hamburg, GermanyZimmermann, A. H.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Ambulantes Krebszentrum, Hamburg, GermanyVisseren-Grul, C. M.论文数: 0 引用数: 0 h-index: 0机构: Lilly Oncol Europe, Houten, Netherlands Ambulantes Krebszentrum, Hamburg, GermanyLeschinger, M., I论文数: 0 引用数: 0 h-index: 0机构: Lilly Deutschland GmbH, Med, Oncol, Bad Homburg, Germany Ambulantes Krebszentrum, Hamburg, GermanyThomas, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg, Thoraxklin, Heidelberg, Germany Ambulantes Krebszentrum, Hamburg, Germany
- [5] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Paz-Ares, Luis论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainDe Marinis, Filippo论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainDediu, Mircea论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainThomas, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainPujol, Jean-Louis论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainBidoli, Paolo论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainMolinier, Oliver论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainSahoo, Tarini Prasad论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainLaack, Eckart论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainReck, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainJaime, Jesus Corral论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainMelemed, Symantha论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainJohn, William J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainChouaki, Nadia论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainZimmermann, Annamaria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainVisseren-Grul, Carla论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, SpainGridelli, Cesare论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Virgen del Rocio, Seville, Spain
- [6] MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC AFTER PEM PLUS CISPLATIN FOR ADVANCED NONSQUAMOUS NSCLC[J]. ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8Obasaju, C. K.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly & Co, Indianapolis, IN 46285 USAPaz-Ares, L. G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Eli Lilly & Co, Indianapolis, IN 46285 USADe Marinis, F.论文数: 0 引用数: 0 h-index: 0机构: San Camillo Forlanini Hosp, Rome, Italy Eli Lilly & Co, Indianapolis, IN 46285 USADediu, M.论文数: 0 引用数: 0 h-index: 0机构: Inst Oncol Bucharest, Bucharest, Romania Eli Lilly & Co, Indianapolis, IN 46285 USAThomas, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg, Thoraxklin, Heidelberg, Germany Eli Lilly & Co, Indianapolis, IN 46285 USAPujol, J. L.论文数: 0 引用数: 0 h-index: 0机构: Montpellier Univ Hosp, Montpellier, France Eli Lilly & Co, Indianapolis, IN 46285 USABidoli, P.论文数: 0 引用数: 0 h-index: 0机构: Az Osped S Gerardo, Monza, Italy Eli Lilly & Co, Indianapolis, IN 46285 USAMolinier, O.论文数: 0 引用数: 0 h-index: 0机构: Le Mans Reg Hosp, Le Mans, France Eli Lilly & Co, Indianapolis, IN 46285 USASahoo, T. P.论文数: 0 引用数: 0 h-index: 0机构: Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, India Eli Lilly & Co, Indianapolis, IN 46285 USALaack, E.论文数: 0 引用数: 0 h-index: 0机构: Ambulantes Krebszentrum Hamburg, Hamburg, Germany Eli Lilly & Co, Indianapolis, IN 46285 USAReck, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Grosshansdorf, Grosshansdorf, Germany Eli Lilly & Co, Indianapolis, IN 46285 USACorral, J.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Suresnes, France Eli Lilly & Co, Indianapolis, IN 46285 USAMelemed, S. A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly & Co, Indianapolis, IN 46285 USAJohn, W. J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly & Co, Indianapolis, IN 46285 USAChouaki, N.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Suresnes, France Eli Lilly & Co, Indianapolis, IN 46285 USAZimmermann, A.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Suresnes, France Eli Lilly & Co, Indianapolis, IN 46285 USAVisseren-Grul, C. M.论文数: 0 引用数: 0 h-index: 0机构: Lilly Oncol Europe, Houten, Netherlands Eli Lilly & Co, Indianapolis, IN 46285 USAGridelli, C.论文数: 0 引用数: 0 h-index: 0机构: SG Moscati Hosp, Div Med Oncol, Avellino, Italy Eli Lilly & Co, Indianapolis, IN 46285 USA
- [7] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)Belani, C. P.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USABrodowicz, T.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USACiuleanu, T.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAKim, J. H.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAKrzakowski, M.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USALaack, E.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAWu, Y. L.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAPeterson, P.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAKrejcy, K.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USAZielinski, C.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA
- [8] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Belani, C. P.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USABrodowicz, T.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USACiuleanu, T.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAKim, J. H.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAKrzakowski, M.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USALaack, E.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAWu, Y. L.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAPeterson, P.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAKrejcy, K.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USAZielinski, C.论文数: 0 引用数: 0 h-index: 0机构: Penn State Hershey Canc Inst, Hershey, PA USA Med Univ Vienna, Gen Hosp, Vienna, Austria CECOG, Vienna, Austria Oncol Inst Ion Chiricuta, Cluj Napoca, Romania CECOG, Cluj Napoca, Romania Yonsei Canc Ctr, Seoul, South Korea Ctr Oncol Inst, Warsaw, Poland CECOG, Warsaw, Poland Univ Hamburg, Ctr Canc, Eppendorf, Germany Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China Eli Lilly & Co, Indianapolis, IN 46285 USA Eli Lilly Reg Operat, Vienna, Austria Med Univ Vienna, Vienna, Austria Med Univ Austria, Vienna, Austria Penn State Hershey Canc Inst, Hershey, PA USA
- [9] Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Ciuleanu, T. E.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaBrodowicz, T.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaBelani, C. P.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaKim, J.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaKrzakowski, M.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaLaack, E.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaWu, Y.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaPeterson, P.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaAdachi, S.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, RomaniaZielinski, C. C.论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Ion Chiricuta, Cluj Napoca, Romania
- [10] Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1713 - 1721Gridelli, Cesare论文数: 0 引用数: 0 h-index: 0机构: S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, Italy S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, Italyde Marinis, Filippo论文数: 0 引用数: 0 h-index: 0机构: San Camillo Forlanini Hosp, Rome, Italy S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyPujol, Jean-Louis论文数: 0 引用数: 0 h-index: 0机构: Montpellier Acad Hosp, Montpellier, France S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyReck, Martin论文数: 0 引用数: 0 h-index: 0机构: Krankenhaus Grosshansdorf, Grosshansdorf, Germany S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyRamlau, Rodryg论文数: 0 引用数: 0 h-index: 0机构: Poznan Univ Med Sci, Wielkopolskie Ctr Pulmonologii Torakochirurg, Poznan, Poland S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyParente, Barbara论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Vila Nova de Gaia, Vila Nova De Gaia, Portugal S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyPieters, Thierry论文数: 0 引用数: 0 h-index: 0机构: Clin Univ St Luc, B-1200 Brussels, Belgium S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyMiddleton, Gary论文数: 0 引用数: 0 h-index: 0机构: Natl Hlth Serv Trust, Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyCorral, Jesus论文数: 0 引用数: 0 h-index: 0机构: Inst Biomed Sevilla IBIS, Seville, Spain Virgen del Rocio Univ Hosp, Seville, Spain S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyWinfree, Katherine论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyMelemed, Symantha论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyZimmermann, Anna论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyJohn, William论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyBeyrer, Julie论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyChouaki, Nadia论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Suresnes, Hauts De Seine, France S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyVisseren-Grul, Carla论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Houten, Netherlands S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, ItalyPaz-Ares, Luis G.论文数: 0 引用数: 0 h-index: 0机构: Inst Biomed Sevilla IBIS, Seville, Spain Virgen del Rocio Univ Hosp, Seville, Spain S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, Italy